| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
108,674,000 |
| Market
Cap: |
72.81(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2298 - $2.97 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 9.4 |
| Insider 3/6 Months : 10 |
|
| Guru Rank Number : 707 |
| Guru Rank Value : 1.9 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
816,825 |
816,825 |
816,825 |
| Total Buy Value |
$0 |
$194,885 |
$194,885 |
$194,885 |
| Total People Bought |
0 |
3 |
3 |
3 |
| Total Buy Transactions |
0 |
4 |
4 |
4 |
| Total Shares Sold |
56,192 |
121,276 |
273,751 |
412,845 |
| Total Sell Value |
$40,460 |
$65,778 |
$342,884 |
$1,024,948 |
| Total People Sold |
5 |
6 |
7 |
9 |
| Total Sell Transactions |
5 |
11 |
22 |
41 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-04-25 |
4 |
AS |
$33.57 |
$131,049 |
I/I |
(3,900) |
308,237 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-04-11 |
4 |
AS |
$36.27 |
$141,453 |
I/I |
(3,900) |
312,137 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-04-10 |
4 |
AS |
$37.04 |
$144,456 |
I/I |
(3,900) |
316,037 |
|
- |
|
| Kim Mina |
Senior VP & General Counsel |
• – – |
2019-04-09 |
4 |
D |
$36.85 |
$135,387 |
D/D |
(3,674) |
66,389 |
|
- |
|
| Newell Joe |
Chief Tech. Operations Officer |
• – – |
2019-04-03 |
4 |
D |
$41.04 |
$26,594 |
D/D |
(648) |
61,498 |
|
- |
|
| Newell Joe |
Chief Tech. Operations Officer |
• – – |
2019-04-01 |
4 |
AS |
$39.96 |
$59,940 |
D/D |
(1,500) |
62,146 |
|
- |
|
| Newell Joe |
Chief Tech. Operations Officer |
• – – |
2019-04-01 |
4 |
OE |
$20.40 |
$30,600 |
D/D |
1,500 |
63,646 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-03-29 |
4 |
AS |
$39.81 |
$155,637 |
I/I |
(3,900) |
319,937 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-03-28 |
4 |
AS |
$36.75 |
$145,909 |
I/I |
(3,900) |
323,837 |
|
- |
|
| Berger Dietmar |
Global Head of R&D |
• – – |
2019-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
90,000 |
|
- |
|
| Newell Joe |
Chief Tech. Operations Officer |
• – – |
2019-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
62,146 |
|
- |
|
| Porter Derrell |
SVP, Head of Global Commercial |
• – – |
2019-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,688 |
|
- |
|
| Kim Mina |
Senior VP & General Counsel |
• – – |
2019-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
70,063 |
|
- |
|
| Koppikar Utpal |
Chief Financial Officer |
• – – |
2019-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
74,063 |
|
- |
|
| Marcus Joel S |
Director |
– • – |
2019-03-15 |
4 |
S |
$38.25 |
$765,000 |
I/I |
(20,000) |
888,355 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-03-15 |
4 |
AS |
$38.73 |
$151,047 |
I/I |
(3,900) |
327,737 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-03-14 |
4 |
AS |
$39.10 |
$156,906 |
I/I |
(3,900) |
331,637 |
|
- |
|
| Newell Joe |
Chief Tech. Operations Officer |
• – – |
2019-03-01 |
4 |
AS |
$36.04 |
$54,202 |
D/D |
(1,500) |
47,146 |
|
- |
|
| Newell Joe |
Chief Tech. Operations Officer |
• – – |
2019-03-01 |
4 |
OE |
$20.40 |
$30,600 |
D/D |
1,500 |
48,646 |
|
- |
|
| Marcus Joel S |
Director |
– • – |
2019-02-28 |
4 |
S |
$36.07 |
$2,257,621 |
D/D |
(62,590) |
7,500 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-02-28 |
4 |
AS |
$36.13 |
$140,907 |
I/I |
(3,900) |
335,537 |
|
- |
|
| Marcus Joel S |
Director |
– • – |
2019-02-27 |
4 |
OE |
$13.20 |
$1,248,015 |
D/D |
62,500 |
70,090 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2019-02-27 |
4 |
AS |
$35.22 |
$140,984 |
I/I |
(3,900) |
339,437 |
|
- |
|
| Haqq Christopher |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-15 |
4 |
AS |
$39.59 |
$30,682 |
D/D |
(775) |
271,943 |
|
- |
|
| Porter Derrell |
SVP, Head of Global Commercial |
• – – |
2019-02-15 |
4 |
AS |
$40.00 |
$236,360 |
D/D |
(5,909) |
21,688 |
|
- |
|
731 Records found
|
|
Page 9 of 30 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.02 (3.03%) 
